Gene · 4171
Papers3,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An integrative evaluation of circadian gene TIMELESS as a pan-cancer immunological and predictive biomarker. | Eur J Med Res | 2023 | 38053143 | PubTator, text mining | PubMed |
| Gene expression alterations predict the pathological complete response in triple-negative breast cancer exploratory analysis of the NACATRINE trial. | Sci Rep | 2023 | 38049525 | PubTator, text mining | PubMed |
| Significance of NotchScore and JAG1 in predicting prognosis and immune response of low-grade glioma. | Front Immunol | 2023 | 38022677 | PubTator, text mining | PubMed |
| Enhanced TP53 reactivation disrupts MYC transcriptional program and overcomes venetoclax resistance in acute myeloid leukemias. | Sci Adv | 2023 | 38019903 | PubTator, text mining | PubMed |
| Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence. | Biomolecules | 2023 | 38002335 | PubTator, text mining | PubMed |
| SIRT1 Prevents R-Loops during Chronological Aging by Modulating DNA Replication at rDNA Loci. | Cells | 2023 | 37998365 | PubTator, text mining | PubMed |
| Transcriptomic landscape based on annotated clinical features reveals PLPP2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma. | J Exp Clin Cancer Res | 2023 | 37996944 | PubTator, text mining | PubMed |
| APC/C prevents non-canonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest. | bioRxiv | 2023 | 37986787 | PubTator, text mining | PubMed |
| Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts. | Aging (Albany NY) | 2023 | 37980163 | PubTator, text mining | PubMed |
| Genome homeostasis defects drive enlarged cells into senescence. | Mol Cell | 2023 | 37977116 | PubTator, text mining | PubMed |
| A Novel Molecular Classification Method for Glioblastoma Based on Tumor Cell Differentiation Trajectories. | Stem Cells Int | 2023 | 37964983 | PubTator, text mining | PubMed |
| Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2. | Cell Death Dis | 2023 | 37963919 | PubTator, text mining | PubMed |
| ASCL1 Is Involved in the Pathogenesis of Schizophrenia by Regulation of Genes Related to Cell Proliferation, Neuronal Signature Formation, and Neuroplasticity. | Int J Mol Sci | 2023 | 37958729 | PubTator, text mining | PubMed |
| DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC. | Cancers (Basel) | 2023 | 37958405 | PubTator, text mining | PubMed |
| The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation. | Sci Rep | 2023 | 37945610 | PubTator, text mining | PubMed |
| Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application. | Cell Rep Med | 2023 | 37944531 | PubTator, text mining | PubMed |
| Diagnostic Significance of Cytokeratin 20 and p53 as Adjunct Immunocytological Markers in Urine Cytology to Detect Urothelial Carcinomas: A Systematic Review Study. | Iran J Pathol | 2023 | 37942190 | PubTator, text mining | PubMed |
| Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome. | NPJ Genom Med | 2023 | 37925498 | PubTator, text mining | PubMed |
| Replisome loading reduces chromatin motion independent of DNA synthesis. | Elife | 2023 | 37906089 | PubTator, text mining | PubMed |
| MmuPV1 E6 induces cell proliferation and other hallmarks of cancer. | mBio | 2023 | 37905801 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4171/papers?page=11